Sequenom, Inc. (SQNM) - Medical Equipment - Deals and Alliances Profile

Date: July 28, 2016
Pages: 66
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: S0B6866071BEN
Leaflet:

Download PDF Leaflet

Sequenom, Inc. (SQNM) - Medical Equipment - Deals and Alliances Profile
Summary

Sequenom, Inc. (Sequenom) is a life sciences company which offers genetic testing that guides reproductive health matters. The company operates CAP (College of American Pathologists) accredited and CLIA (Clinical Laboratory Improvements Amendment) certified molecular diagnostics clinical laboratory (MDCL) that specializes in the field of in prenatal health. Sequenom offers wide collection of carrier status, noninvasive prenatal testing, and diagnostic test options ranging from baby’s whole genome assessment to specific conditions identification which allows parents and physicians to select the right test for each pregnancy. The molecular genetic laboratory-developed tests offer early patient management information for geneticists, maternal fetal medicine specialists, and obstetricians as well as patients. Its MDCLs are located at San Diego, California; Raleigh-Durham, North Carolina; and Grand Rapids, Michigan. Sequenom is headquartered in San Diego, California, the US.

Sequenom, Inc. (SQNM) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
Sequenom, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment, Deal Details
Asset Purchase
Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million
Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million
Partnerships
Sequenom Enters into Licensing Agreement with Mayo Medical Labs
Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS
Sequenom Enters Into Licensing Agreement With LifeCodexx
Sequenom Enters Into Licensing Agreement With Optherion
Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests
Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing
New England Biolabs Enters Into Licensing Agreement With Sequenom
Equity Offering
Sequenom Completes Public Offering Of Common Stock For US$62 Million
Sequenom Completes Public Offering Of US$96.6 Million
SEQUENOM Completes Private Placement Of Common Stock For US$51.6 Million
Debt Offering
Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million
Asset Transactions
Sequenom Plans to Sell Clinical Genomic Lab in North Carolina
Acquisition
Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million
Sequenom, Inc. - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Mar 02, 2016: Sequenom Announces Contract with Anthem BlueCross
Jan 07, 2016: Sequenom Announces Restructuring: Plans Sale Of North Carolina Operations And Initiatives To Improve Efficiencies
May 27, 2015: Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities
Financial Announcements
May 04, 2016: Sequenom Reports First Quarter 2016 Results
Mar 02, 2016: Sequenom Reports 2015 Financial Results
Nov 04, 2015: Sequenom Reports Financial Results For The Third Quarter Of 2015
Aug 05, 2015: Sequenom Reports Financial Results For The Second Quarter Of 2015
May 06, 2015: Sequenom Reports Financial Results For The First Quarter Of 2015
Mar 04, 2015: Sequenom Reports 2014 Final And Fourth Quarter Financials
Corporate Communications
Apr 12, 2016: Sequenom Strengthens Executive Team with New Vice President of Sales
Sep 21, 2015: Sequenom Announces Appointment of Dirk van den Boom as Interim President and CEO
Jun 18, 2015: Sequenom Welcomes Catherine J. Mackey, Ph.D., To Board Of Directors
Mar 17, 2015: Kenneth Buechler Elected Chairman of Sequenom Board of Directors
Legal and Regulatory
Jun 27, 2016: The Supreme Court Of The United States Denies Sequenom's Petition Requesting Review Of Decision On '540 Patent
Mar 21, 2016: Sequenom Files Petition With the Supreme Court of the United States Requesting Review Of Decision On '540 Patent
Dec 02, 2015: Sequenom Comments On U.S. Court Of Appeals For The Federal Circuit Decision On '540 Patent
Jun 12, 2015: Sequenom Comments On U.S. Court Of Appeals For The Federal Circuit Ruling On '540 Patent
Product News
Feb 25, 2016: Sequenom Laboratories Announces Positive Results from Clinical Validation Study on the MaterniT GENOME Test
Jan 11, 2016: Sequenom Provides Update On MaterniT Genome Test
Mar 19, 2015: Sequenom And Recombine Launch HerediT Universal Carrier Screening Test
Other Significant Developments
May 03, 2016: Sequenom Announces In-Network Contracts with Anthem Blue Cross and Blue Shield Plans for Georgia, Indiana, Kentucky, Missouri, Ohio, Virginia and Wisconsin
Apr 19, 2016: Sequenom Completes Consolidation of North Carolina Operations
Jan 11, 2016: Sequenom Announces Preliminary 2015 Results
Sep 02, 2015: Sequenom Partners With The Perinatal Quality Foundation
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Sequenom, Inc., Medical Equipment, Key Facts, 2015
Sequenom, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Sequenom, Inc., Deals By Market, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016
Sequenom Acquires Noninvasive Prenatal Testing Intellectual Property from Isis Innovation for USD14.5 Million
Sequenom Acquires Molecular Diagnostic Application Patents From Helicos BioSciences For US$1.3 Million
Sequenom Enters into Licensing Agreement with Mayo Medical Labs
Sequenom Enters Into Licensing Agreement With Laboratoire Cerba For MaterniT21 PLUS
Sequenom Enters Into Licensing Agreement With LifeCodexx
Sequenom Enters Into Licensing Agreement With Optherion
Cypher Genomics Enters into Agreement with Sequenom to Develop Next Generation Noninvasive Prenatal Tests
Enzo Clinical Labs And Sequenom Enter Into Agreement To Market MaterniT21 Plus
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing
New England Biolabs Enters Into Licensing Agreement With Sequenom
Sequenom Completes Public Offering Of Common Stock For US$62 Million
Sequenom Completes Public Offering Of US$96.6 Million
SEQUENOM Completes Private Placement Of Common Stock For US$51.6 Million
Sequenom Completes Private Placement Of Notes Due 2017 For US$130 Million
Sequenom Plans to Sell Clinical Genomic Lab in North Carolina
Agena Bioscience Completes Acquisition of Sequenom Bioscience for USD31.8 Million
Sequenom, Inc., Key Competitors
Sequenom, Inc., Key Employees
Sequenom, Inc., Other Locations
Sequenom, Inc., Subsidiaries

LIST OF FIGURES

Sequenom, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016
Sequenom, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016
Skip to top


Ask Your Question

Sequenom, Inc. (SQNM) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: